Pharmacokinetics of Ceftazidime/Avibactam Following Intravenous Administration in Rabbits: Developing the Preclinical Foundation for Treatment of KPC-Kp Pneumonia in Immunocompromised Patients

BACKGROUND: CRE have been identified by the CDC as one of three urgent antibiotic resistance threats. The international emergence of these pathogens has largely been driven by the dissemination of carbapenemase-producing Klebsiella pneumoniae (KPC-Kp), through enzymes that hydrolyze carbapenems and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Petraitis, Vidmantas, Petraitiene, Ruta, Satlin, Michael, Maung, Bo Bo Win, Khan, Farehin, Mazur, Chase, Georgiades, Benjamin, Hayden, Joshua A, Walsh, Thomas J
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632020/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.660
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires